Drw Securities, LLC Alpine Immune Sciences, Inc. Transaction History

Drw Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$2.15 - $4.41 $21,500 - $44,100	-10,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$4.09 - $7.19 $76,483 - $134,453	-18,700 Reduced 65.16%	10,000 $69,000
Q3 2018 Nov 14, 2018	BUY	$5.68 - $8.59 $24,747 - $37,426	4,357 Added 17.9%	28,700 $182,000
Q2 2018 Aug 14, 2018	BUY	$7.16 - $10.05 $101,263 - $142,137	14,143 Added 138.66%	24,343 $184,000
Q1 2018 May 14, 2018	BUY	$7.95 - $11.65 $81,090 - $118,830	10,200 New	10,200 $82,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.